Biodesix PEG Ratio

The latest PEG ratio for BDSX is 20.05. That is above the Healthcare sector average of 12.15. Investors often review this figure alongside Biodesix's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, BDSX currently prints 20.05 for PEG ratio, while the sector average sits near 12.15. That is roughly 65.0% above the sector mean. Large gaps often invite a closer look at Biodesix's growth, margins, and balance sheet.

A PEG ratio of 20.05 for Biodesix is not 'good' or 'bad' on its own. Compare it with the peer average (12.15) and with BDSX's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting BDSX's PEG ratio (20.05), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Biodesix's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.